← Back to headlines
Lilly's Zepbound-Containing Regimen Succeeds in Psoriasis Trial
Lilly announced that a regimen including its drug Zepbound demonstrated success in a clinical trial for treating psoriasis.
18 Feb, 12:26 — 18 Feb, 12:28
The Story
Analyzing sources…
Source Diversity
Source Diversity
Moderate (27/100)2 sources— more sources would strengthen this score15/33
Spectrum spread— 2/5 buckets covered8/33
Far L
Left1
Left (1)
cnbc
Center
Right1
Right (1)
seeking-alpha
Far R
Geographic diversity— 1 region4/34
US2
ℹAll sources from US region
ℹOnly 2 sources cover this story
Sources
Showing 2 of 2 sources
cnbcMostly Factual191d ago
Lilly's Zepbound and Taltz improve psoriasis symptoms, drive weight loss in study
Eli Lilly said on Wednesday the combined use of its weight-loss drug Zepbound with psoriasis treatment Taltz showed better results in a late-stage study.
Read full article →seeking-alphaMixed191d ago
Lilly says Zepbound-containing regimen succeeded in a trial for psoriasis
Read full article →Coverage Timeline
First report: seeking-alpha · 18 Feb, 12:26|Full coverage: 2 · 2m|Window: 2m
Left-leaningCenterRight-leaning
Related Stories
Dutch Health Agency Warns of Potentially Fatal Trump-Shaped Ecstasy Pills
35m ago
48-Year-Old Anesthesiologist Found Dead in Greek Hospital On-Call Room
2h ago
Art World Mourns Yayoi Kusama as Tributes Highlight Her Lasting Creative Legacy
3h ago
Study Reveals Hidden Arterial Calcification in Young Adults
4h ago